Related Experiment Video
Updated: Jul 3, 2026

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
Published on: June 5, 2021
Surveillance of circulating SARS-CoV-2 variants in the Republic of Serbia during 2024
Luka Dragačević1, Bojana Beleslin Čokić1, Aleksandra Knežević2
1Institute of Virology, Vaccines and Sera "Torlak", Belgrade, Republic of Serbia.
Objectives:
The COVID-19 epidemic, caused by SARS-CoV-2, has spread worldwide and remains a major public health challenge. The objective of this study was to assess the prevalence of COVID-19 and characterize the circulating SARS-CoV-2 lineages in the Republic of Serbia during 2024.
Methods:
We analyzed SARS-CoV-2-positive samples collected throughout 2024 in Serbia. Viral lineages were identified based on sequencing of the gene encoding the spike protein. The distribution of detected lineages was compared with available European data to evaluate regional differences in variant circulation.
Results:
The distribution of SARS-CoV-2 lineages in Serbia differed substantially from the European average. The most prevalent variant detected in Serbia was JN.1.16, whereas KP.3.1.1 predominated in Europe. In addition, 95% of analyzed viral sequences contained the ins_S:16:MPLF insertion, a characteristic feature of the GRA clade.
Conclusion:
These findings demonstrate that the distribution of SARS-CoV-2 lineages in Serbia in 2024 differed from the average European distribution in 2024. The observed differences should be considered when evaluating the need for booster vaccination and optimizing national vaccination strategies. To our knowledge, this study provides the only available data on SARS-CoV-2 lineage circulation in Serbia for 2024.
Related Concept Videos
Principles of Disease Surveillance
Investigation of Disease Outbreaks
Coronavirus

